Tilray Inc sell tbackenh
Summary
This prediction ended on 24.09.18 with a price of €98.36. tbackenh correctly predicted massive losses of -49.06% for Tilray Inc. tbackenh has 50% into this predictionTilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Tilray Inc | -14.105% | -14.105% | -78.620% | - |
| iShares Core DAX® | -2.385% | 3.986% | 16.836% | 16.377% |
| iShares Nasdaq 100 | -4.527% | -0.258% | 18.824% | 29.987% |
| iShares Nikkei 225® | -4.129% | 4.382% | 10.912% | -1.507% |
| iShares S&P 500 | -2.885% | 1.387% | 20.391% | 35.258% |
According to tbackenh what are the pros and cons of Tilray Inc for the foreseeable future?
Pros
Cons
Comments by tbackenh for this prediction
In the thread Tilray Inc diskutieren
tbackenh stimmt der Sell-Einschätzung von kyron7htx zu
tbackenh stimmt am 19.09.2018 der Sell-Einschätzung von kyron7htx mit dem Kursziel 120$
Hier sind Korrekturen in Form von Gewinnmitnahmen sehr wahrscheinlich.
Stopped prediction by tbackenh for Tilray Inc
Tilray Inc
02.09.21
02.09.22
02.09.22
